260 related articles for article (PubMed ID: 12468800)
1. Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors.
Saulle E; Centonze D; Martín AB; Moratalla R; Bernardi G; Calabresi P
Stroke; 2002 Dec; 33(12):2978-84. PubMed ID: 12468800
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic enhancement of excitatory synaptic transmission in layer II entorhinal neurons is dependent on D₁-like receptor-mediated signaling.
Glovaci I; Caruana DA; Chapman CA
Neuroscience; 2014 Jan; 258():74-83. PubMed ID: 24220689
[TBL] [Abstract][Full Text] [Related]
3. Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission.
Arcangeli S; Tozzi A; Tantucci M; Spaccatini C; de Iure A; Costa C; Di Filippo M; Picconi B; Giampà C; Fusco FR; Amoroso S; Calabresi P
J Cereb Blood Flow Metab; 2013 Feb; 33(2):278-86. PubMed ID: 23149555
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity.
Centonze D; Grande C; Saulle E; Martin AB; Gubellini P; Pavón N; Pisani A; Bernardi G; Moratalla R; Calabresi P
J Neurosci; 2003 Sep; 23(24):8506-12. PubMed ID: 13679419
[TBL] [Abstract][Full Text] [Related]
5. The Cdk5 inhibitor Roscovitine increases LTP induction in corticostriatal synapses.
Miranda-Barrientos J; Nieto-Mendoza E; Hernández-Echeagaray E
ASN Neuro; 2014 Mar; 6(2):. PubMed ID: 24555476
[TBL] [Abstract][Full Text] [Related]
6. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis.
West AR; Grace AA
J Neurosci; 2002 Jan; 22(1):294-304. PubMed ID: 11756513
[TBL] [Abstract][Full Text] [Related]
7. Dopamine-dependent synaptic plasticity in the striatal cholinergic interneurons.
Suzuki T; Miura M; Nishimura K; Aosaki T
J Neurosci; 2001 Sep; 21(17):6492-501. PubMed ID: 11517238
[TBL] [Abstract][Full Text] [Related]
8. Expression of N-methyl-D-aspartate receptor-dependent long-term potentiation in the neostriatal neurons in an in vitro slice after ethanol withdrawal of the rat.
Yamamoto Y; Nakanishi H; Takai N; Shimazoe T; Watanabe S; Kita H
Neuroscience; 1999; 91(1):59-68. PubMed ID: 10336060
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
Calabresi P; Mercuri NB; Sancesario G; Bernardi G
Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
[TBL] [Abstract][Full Text] [Related]
10. D1 dopamine receptor-induced cyclic AMP-dependent protein kinase phosphorylation and potentiation of striatal glutamate receptors.
Price CJ; Kim P; Raymond LA
J Neurochem; 1999 Dec; 73(6):2441-6. PubMed ID: 10582604
[TBL] [Abstract][Full Text] [Related]
11. Chronic constant light-induced hippocampal late-phase long-term potentiation impairment in vitro is attenuated by antagonist of D1/D5 receptors.
Chai AP; Ma WP; Wang LP; Cao J; Xu L; Yang YX; Mao RR
Brain Res; 2015 Oct; 1622():72-80. PubMed ID: 26115584
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate amplifies long-term potentiation in rat hippocampus CA1 area involving the insertion of AMPA receptors by activation of β-adrenergic and D1/D5 receptors.
Rozas C; Carvallo C; Contreras D; Carreño M; Ugarte G; Delgado R; Zeise ML; Morales B
Neuropharmacology; 2015 Dec; 99():15-27. PubMed ID: 26165920
[TBL] [Abstract][Full Text] [Related]
13. Dopamine facilitates long-term depression of glutamatergic transmission in rat prefrontal cortex.
Otani S; Blond O; Desce JM; Crépel F
Neuroscience; 1998 Aug; 85(3):669-76. PubMed ID: 9639264
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine prevents post-ischemic LTP via presynaptic and postsynaptic mechanisms.
Zhou L; Qin SJ; Gao X; Han JP; Hu B; Li M; Wu YQ; Ma X; Gu SL; Ma TF
Brain Res; 2015 Oct; 1622():308-20. PubMed ID: 26168895
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro.
Kerr JN; Wickens JR
J Neurophysiol; 2001 Jan; 85(1):117-24. PubMed ID: 11152712
[TBL] [Abstract][Full Text] [Related]
16. Plasticity of first-order sensory synapses: interactions between homosynaptic long-term potentiation and heterosynaptically evoked dopaminergic potentiation.
Kumar SS; Faber DS
J Neurosci; 1999 Mar; 19(5):1620-35. PubMed ID: 10024349
[TBL] [Abstract][Full Text] [Related]
17. Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition.
Mazzocchetti P; Mancini A; Sciaccaluga M; Megaro A; Bellingacci L; Di Filippo M; Cesarini EN; Romoli M; Carrano N; Gardoni F; Tozzi A; Calabresi P; Costa C
Neurobiol Dis; 2020 Jul; 140():104848. PubMed ID: 32222474
[TBL] [Abstract][Full Text] [Related]
18. MPTP modulates hippocampal synaptic transmission and activity-dependent synaptic plasticity via dopamine receptors.
Zhu G; Huang Y; Chen Y; Zhuang Y; Behnisch T
J Neurochem; 2012 Aug; 122(3):582-93. PubMed ID: 22651101
[TBL] [Abstract][Full Text] [Related]
19. Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors.
Centonze D; Usiello A; Costa C; Picconi B; Erbs E; Bernardi G; Borrelli E; Calabresi P
J Neurosci; 2004 Sep; 24(38):8214-22. PubMed ID: 15385604
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D1 receptors and group I metabotropic glutamate receptors contribute to the induction of long-term potentiation in the nucleus accumbens.
Schotanus SM; Chergui K
Neuropharmacology; 2008 Apr; 54(5):837-44. PubMed ID: 18272187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
